Health Condition 1: Q670- Congenital facial asymmetry
Conditions
Interventions
Control Intervention1: intramuscular and sublingual atropine: In this study we compare antisialagogue effect of atropine via 2 routes- intramuscular and sublingual as premedication by weighing dental
Sponsors
Dr Sneha
Eligibility
Inclusion criteria
Inclusion criteria: Individuals aged 10-30 years, undergoing elective surgeries, under general anesthesia, Requiring antisialagogue premedication, American Society of Anesthesiologists (ASA) Physical Status 1 and 2
Exclusion criteria
Exclusion criteria: Presence of significant oral pathology like oral malignancies, recent history of aphthous ulcers,Patients with history of urinary retention, Patients with severe cardiorespiratory disorders,Patients with xerostomia and/or xeropthalmia, Any allergy to atropine, History of smoking, History of recent or current upper respiratory tract infection,Angle closure glaucoma, Severe hepatic and renal diseases, Patient on any medications interfering with salivation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the quantity of saliva produced 45 minutes after introducing atropine via sublingual and intramuscular routes in gramsTimepoint: 45 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To assess and compare dryness caused by atropine administered via sublingual and intramuscular routes 2.To estimate the changes in cardiovascular system by atropine via sublingual and IM routes by non-invasive blood pressure (systolic BP, diastolic BP, mean arterial pressure), heart rate, temperature Timepoint: HR - beats/minute BP- mm Hg temperature- degree celcius | — |
Countries
India
Contacts
Public ContactDr Sneha S
KS hegde medical academy
Outcome results
None listed